BlackRock
YARW

BlackRock’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

BlackRock’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.5K Hold
888
– – ﹤0.01% 5252
2025
Q4 		$25.8K Hold
888
– – ﹤0.01% 5173
2025
Q3 		$14.9K Hold
888
– – ﹤0.01% 5185
2025
Q2 		$73.3K Sell
888
-764
-46% -$49.7K ﹤0.01% 4908
2025
Q1 		$130K Sell
1,652
-14
-0.8% -$1.72K ﹤0.01% 4699
2024
Q4 		$279K Buy
1,666
+5
+0.3% +$654 ﹤0.01% 4558
2024
Q3 		$156K Buy
1,661
+449
+37% +$42.6K ﹤0.01% 4579
2024
Q2 		$119K Buy
1,212
+320
+36% +$39.9K ﹤0.01% 4663
2024
Q1 		$137K Sell
892
-54
-6% -$5.82K ﹤0.01% 4669
2023
Q4 		$110K Buy
946
+47
+5% +$7.32K ﹤0.01% 4780
2023
Q3 		$182K Sell
899
-83
-8% -$18.1K ﹤0.01% 4707
2023
Q2 		$201K Hold
982
– – ﹤0.01% 4730
2023
Q1 		$151K Sell
982
-2
-0.2% -$359 ﹤0.01% 4861
2022
Q4 		$133K Sell
984
-2
-0.2% -$400 ﹤0.01% 4959
2022
Q3 		$197K Sell
986
-2
-0.2% -$640 ﹤0.01% 4979
2022
Q2 		$346K Sell
988
-126
-11% -$52.9K ﹤0.01% 4880
2022
Q1 		$652K Sell
1,114
-5
-0.4% -$2.97K ﹤0.01% 4800
2021
Q4 		$1.03M Sell
1,119
-34
-3% -$36.5K ﹤0.01% 4660
2021
Q3 		$1.44M Hold
1,153
– – ﹤0.01% 4450
2021
Q2 		$3.64M Sell
1,153
-2,855
-71% -$11.3M ﹤0.01% 4011
2021
Q1 		$24.7M Buy
4,008
+678
+20% +$4.92M ﹤0.01% 3066
2020
Q4 		$18.9M Buy
3,330
+595
+22% +$3.74M ﹤0.01% 3035
2020
Q3 		$16.3M Buy
2,735
+453
+20% +$2.64M ﹤0.01% 2974
2020
Q2 		$14.2M Buy
2,282
+1,459
+177% +$9.88M ﹤0.01% 2990
2020
Q1 		$7.94M Buy
823
+557
+209% +$8.74M ﹤0.01% 3115
2019
Q4 		$4.44M Buy
266
+3
+1% +$50K ﹤0.01% 3543
2019
Q3 		$4.24M Buy
263
+9
+4% +$145K ﹤0.01% 3531
2019
Q2 		$5.47M Buy
254
+79
+45% +$1.95M ﹤0.01% 3507
2019
Q1 		$4.95M Buy
175
+22
+14% +$528K ﹤0.01% 3418
2018
Q4 		$2.27M Buy
153
+6
+4% +$134K ﹤0.01% 3627
2018
Q3 		$5.2M Buy
147
+21
+17% +$648K ﹤0.01% 3497
2018
Q2 		$3.68M Sell
126
-1
-0.8% -$38.9K ﹤0.01% 3566
2018
Q1 		$17.2M Buy
+127
New +$15.4M ﹤0.01% 2850

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock's YARW Position: Q1 2026 in Review

BlackRock held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2026 at 888 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5252.

BlackRock first reported a position in YARW in Q1 2018 and has held it in 33 quarters since. The position peaked at $24.7M in Q1 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • BlackRock held 888 shares of Yarrow Bioscience, Inc. Common Stock worth $26.5K as of Q1 2026.
  • BlackRock left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5252 holding.
  • BlackRock first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and has held it in 33 quarters since.
  • BlackRock's Yarrow Bioscience, Inc. Common Stock position peaked at $24.7M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.